JENA (dpa-AFX) - The medical technology group Carl Zeiss Med itec intends to buy back its own shares for up to 150 million euros. Based on Friday's closing price of 98.48 euros, this would correspond to a good 1.5 million shares and around 1.7 percent of the company's share capital, the company announced in Jena on Monday. The share price recently fell by 0.65 percent on Monday.

The share buyback is expected to begin on February 9 and will have a maximum term of one year. The shares are to be bought back via the stock exchange. The company had the share buyback authorized by its shareholders in the summer of 2020, but has not yet made use of the authorization./mne/jha/